Christopher Capelli - Aug 11, 2025 Form 4 Insider Report for Autonomix Medical, Inc. (AMIX)

Role
Director
Signature
/s/ Trent Smith, Attorney-in-Fact for Christopher Capelli
Stock symbol
AMIX
Transactions as of
Aug 11, 2025
Transactions value $
$0
Form type
4
Date filed
8/13/2025, 09:16 PM
Previous filing
Jan 26, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Capelli Christopher Director 21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS /s/ Trent Smith, Attorney-in-Fact for Christopher Capelli 2025-08-13 0001768585

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMIX Option (Right to buy) Disposed to Issuer -3.75K -100% 0 Aug 11, 2025 Common Stock 3.75K $40.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received no consideration for the cancellation.